Can an isolated pathogen-specific IgM elevation prove ongoing infection?

Pathogen-specific IgM is often treated as a marker of recent infection, but its diagnostic meaning is limited when it is isolated or discordant with the clinical picture. The claim is well supported: IgM positivity alone does not establish that an infection is currently active.

Persistence after resolution

• IgM can remain detectable long after clinical recovery. Following treated Lyme disease, Borrelia burgdorferi IgM reactivity was found 10–20 years later in 10% of people previously treated for early disease and 15% treated for Lyme arthritis.
• For Mycoplasma pneumoniae, IgM commonly persists for months: one follow-up study estimated loss of detectable IgM at roughly 12–26 weeks after symptom onset, while individual pediatric cases remained positive for nearly 10 months or over 15 months.
• Thus, a positive IgM may represent immunologic residue of prior infection rather than relapse, treatment failure, or reinfection.

False positivity and cross-reactivity

• IgM assays vary substantially in specificity. In commercial M. pneumoniae evaluations, specificity ranged from 25%–100% in one comparison and 49%–100% in another; some tests falsely reacted with acute Epstein–Barr virus sera.
• Nonspecific binding, antigen-preparation features, rheumatoid factor/other autoantibodies, and antibodies associated with EBV or syphilis can create apparent pathogen-specific IgM reactivity. In a retrospective review of referred positive Lyme IgM immunoblots, 53% were judged false positive.
• For Lyme disease, IgM immunoblot interpretation is intended only during the first 30 days of symptoms; later isolated IgM should be disregarded.

Clinical implications

• Interpretation should incorporate the syndrome, symptom timing, exposure probability, and assay methodology. Compatible clinical findings plus respiratory NAAT/PCR, validated two-tier serology, or paired sera showing seroconversion or a substantial—often fourfold—IgG rise provide stronger evidence of recent or active infection.

Bottom line

• An isolated IgM elevation is a nonspecific clue, not proof of ongoing infection; persistence, assay-dependent false reactivity, and cross-reactivity make confirmation and clinical correlation essential.